Madelon C Vonk

11.7k total citations · 1 hit paper
119 papers, 2.7k citations indexed

About

Madelon C Vonk is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Dermatology. According to data from OpenAlex, Madelon C Vonk has authored 119 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Pathology and Forensic Medicine, 57 papers in Pulmonary and Respiratory Medicine and 26 papers in Dermatology. Recurrent topics in Madelon C Vonk's work include Systemic Sclerosis and Related Diseases (105 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers) and Dermatologic Treatments and Research (23 papers). Madelon C Vonk is often cited by papers focused on Systemic Sclerosis and Related Diseases (105 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers) and Dermatologic Treatments and Research (23 papers). Madelon C Vonk collaborates with scholars based in Netherlands, United States and Germany. Madelon C Vonk's co-authors include F.H.J. van den Hoogen, Oliver Distler, Dinesh Khanna, Christopher P. Denton, Ulf Müller‐Ladner, James R. Seibold, Vallerie V. McLaughlin, Janet Pope, Diana Bonderman and Gerry Coghlan and has published in prestigious journals such as International Journal of Molecular Sciences, CHEST Journal and Frontiers in Immunology.

In The Last Decade

Madelon C Vonk

112 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

2013 541 citations Christopher P. Denton, Oliver Distler et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Madelon C Vonk

Since Specialization

Citations

This map shows the geographic impact of Madelon C Vonk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madelon C Vonk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madelon C Vonk more than expected).

Fields of papers citing papers by Madelon C Vonk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madelon C Vonk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madelon C Vonk. The network helps show where Madelon C Vonk may publish in the future.

Co-authorship network of co-authors of Madelon C Vonk

This figure shows the co-authorship network connecting the top 25 collaborators of Madelon C Vonk. A scholar is included among the top collaborators of Madelon C Vonk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madelon C Vonk. Madelon C Vonk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hand function impairment in Systemic sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) – a longitudinal observational multicentre study protocol 2025 ·BMJ Open ·(unknown), Voon H Ong, Christopher P. Denton, Wouter Foppen, (unknown), (unknown), Marion C Kortekaas, (unknown), Douwe J. Mulder, (unknown), Madelon C Vonk, Jeska K de Vries‐Bouwstra, Paco M J Welsing, S.C. Mastbergen, Julia Spierings	1
2	A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score 2025 ·Lara D. Veeken ·Cosimo Bruni, Lorenzo Tofani, Håvard Fretheim, (unknown), (unknown), (unknown), (unknown), Ilaria Galetti, (unknown), Mike Oliver Becker, Anna‐Maria Hoffmann‐Vold, Jeska K de Vries‐Bouwstra, Madelon C Vonk, Jörg H. W. Distler, Marco Matucci‐Cerinic, Oliver Distler	1
3	Longitudinal association between nailfold capillaroscopy and incident interstitial lung disease: A EUSTAR database analysis 2025 ·Journal of Scleroderma and Related Disorders ·(unknown), Jeska K de Vries‐Bouwstra, Jörg Henes, László Czirják, Lorenzo Dagna, (unknown), Yannick Allanore, Rosario Foti, Juan José Alegre Sancho, Britta Maurer, Giovanna Cuomo, Julia Spierings, Thierry Martin, Marie‐Elise Truchetet, C.H.M. van den Ende, Madelon C Vonk	0
4	Experiences of systemic sclerosis patients with home monitoring of their pulmonary function: a qualitative study 2024 ·Rheumatology Advances in Practice ·(unknown), (unknown), Madelon C Vonk, C.H.M. van den Ende	1
5	POS0203 EVIDENCE-BASED EXPERT CONSENSUS DEFINITION OF ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS – A EUSTAR STUDY 2024 ·Annals of the Rheumatic Diseases ·Anna‐Maria Hoffmann‐Vold, (unknown), Ishita Barua, (unknown), (unknown), Ana Maria Gheorghiu, (unknown), Madelon C Vonk, (unknown), Andrea Gabrielli, Oliver Distler	0
6	Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile 2024 ·Lara D. Veeken ·(unknown), (unknown), A. van Caam, Jacqueline L Vos, E.L. Vitters, (unknown), Sander I. van Leuven, Marije I. Koenders, P.M. van der Kraan, Hans J. P. M. Koenen, Ruben L. Smeets, Robin Nijveldt, Madelon C Vonk, Rogier M. Thurlings	1
7	Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease 2024 ·Advanced Healthcare Materials ·(unknown), (unknown), Madelon C Vonk, Wouter P. R. Verdurmen, Séverine Le Gac	3
8	Physical Therapy in Systemic Sclerosis: The Patient Perspective 2021 ·Arthritis Care & Research ·(unknown), (unknown), T. P. M. Vliet Vlieland, (unknown), C.H.M. van den Ende, (unknown), (unknown), Julia Spierings, Madelon C Vonk, Jeska K de Vries‐Bouwstra	5
9	From “being at war” to “getting back on your feet”: A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation 2020 ·Journal of Scleroderma and Related Disorders ·Julia Spierings, (unknown), (unknown), Arwen H. Pieterse, Madelon C Vonk, Alexandre E. Voskuyl, Jeska K de Vries‐Bouwstra, J.M. van Laar, Marijke C. Kars	5
10	Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study 2020 ·Annals of the Rheumatic Diseases ·(unknown), Jeska de Vries‐Bouwstra, C.H.M. van den Ende, (unknown), (unknown), Bram Geurts, Miranda Snoeren, Anne A. Schouffoer, Julia Spierings, Jacob M. van Laar, T. Huizinga, Alexandre E. Voskuyl, Erik W.A. Marijt, Walter J. F. M. van der Velden, F.H.J. van den Hoogen, Madelon C Vonk	40
11	Room for improvement in non-pharmacological systemic sclerosis care?—a cross-sectional online survey of 650 patients 2020 ·Lara D. Veeken ·(unknown), Madelon C Vonk, (unknown), Maria W. G. Nijhuis–van der Sanden, J. Bart Staal, Ton Satink, C.H.M. van den Ende	1
12	How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality? 2019 ·Lara D. Veeken ·Julia Spierings, C.H.M. van den Ende, (unknown), Hein J. Bernelot Moens, (unknown), Femke Bonte‐Mineur, (unknown), (unknown), (unknown), Jacob M. van Laar, Douwe J. Mulder, Judith Potjewijd, (unknown), (unknown), Anne A. Schouffoer, Alja J. Stel, (unknown), Alexandre E. Voskuyl, Jeska K de Vries‐Bouwstra, Madelon C Vonk, (unknown)	13
13	Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient’s perspective 2019 ·Lara D. Veeken ·Julia Spierings, (unknown), (unknown), (unknown), Arwen H. Pieterse, Madelon C Vonk, Alexandre E. Voskuyl, Jeska K de Vries‐Bouwstra, Marijke C. Kars, Jacob M. van Laar	14
14	Optimal care for systemic sclerosis patients: recommendations from a patient-centered and multidisciplinary mixed-method study and working conference 2018 ·Clinical Rheumatology ·Julia Spierings, C.H.M. van den Ende, (unknown), (unknown), Hein J. Bernelot Moens, Jacob M. van Laar, Jeska de Vries‐Bouwstra, Madelon C Vonk	18
15	Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy 2017 ·RMD Open ·(unknown), Anton Vonk Noordegraaf, Frank Oosterveer, Piet LCM van Riel, Madelon C Vonk	5
16	Three-year trajectories of disability and fatigue in systemic sclerosis: a cohort study. 2017 ·PubMed ·(unknown), Linda Kwakkenbos, Madelon C Vonk, F.H.J. van den Hoogen, T. P. M. Vliet Vlieland, C.H.M. van den Ende	7
17	Increased fascial thickness of the deltoid muscle in dermatomyositis and polymyositis: An ultrasound study 2015 ·Muscle & Nerve ·(unknown), (unknown), Baziel G.M. van Engelen, Madelon C Vonk, Piet L. van Riel, Sigrid Pillen	28
18	Predictors of long-term survival in pulmonary hypertension treated with bosentan 2011 ·The Journal of Heart and Lung Transplantation ·Paul Bresser, Jeroen C. Vis, Rolf M.F. Berger, Hubert W. Vliegen, Madelon C Vonk, Repke J. Snijder, Leon M. van den Toorn, Arie P.J. van Dijk, Karin A. Boomars, (unknown), Barbara J.M. Mulder	1
19	Addressing patient health care demands in systemic sclerosis: pre-post assessment of a psycho-educational group programme. 2011 ·PubMed ·Linda Kwakkenbos, (unknown), Madelon C Vonk, (unknown), C.H.M. van den Ende, F.H.J. van den Hoogen, W.G.J.M. van Lankveld	18
20	Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis 2007 ·Annals of the Rheumatic Diseases ·Madelon C Vonk, Zora Marjanovic, F.H.J. van den Hoogen, Sarah Zohar, A Schattenberg, WE Fibbe, (unknown), Éliane Gluckman, Frank Preijers, Arie P.J. van Dijk, J. J. Bax, P. Roblot, P. L. C. M. van Riel, Jacob M. van Laar, Dominique Farge	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact